Størrelsen af vægtøgningen og andelen af unge patienter som havde en klinisk signifikant vægtøgning var højere ved langvarig behandling (mindst 24 uger) end ved kortvarig behandling.
47 magnitude of weight gain and the proportion of adolescent patients who had clinically significant weight gain were greater with long-term exposure (at least 24 weeks) than with short-term exposure.